Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tenjove NewHemp Biotech is a China-based industrial hemp subsidiary established by Shineco to build a vertically integrated hemp supply chain spanning cultivation, harvesting, primary processing, and fine extraction. The business has been described as focusing on high-CBD hemp, cannabidiol extraction, and downstream consumer products including CBD beauty masks and CBD-related food products. Available public disclosures position the company more as an industrial hemp and cannabinoid commercialization vehicle than a traditional drug-development biotech with a disclosed therapeutic pipeline. It appears to operate as part of Shineco's broader plant-based health and wellness strategy in China.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tenjove NewHemp Biotech.